Published on: Jan 28, 2026
This prestigious award supports researchers as they transition into new areas of inquiry within the biology of aging. For Dr. Camell, a faculty member at the Masonic Institute on the Biology of Aging and Metabolism (MIBAM), it represents both recognition of her lab’s achievements and an opportunity to pursue innovative research directions.
Dr. Camell’s interest in aging began during her college years while working as a nurse aide in a nursing home, where she witnessed the challenges of aging and immune decline firsthand. That experience inspired her to explore how aging influences disease and health. Since establishing her lab in 2019 within the Department of Biochemistry, Molecular Biology and Biophysics, her research has focused on understanding how the immune system becomes dysfunctional with age, with an emphasis on promoting healthy aging.
Selected through a highly competitive process, the award funds Dr. Camell’s investigation into macrophages key immune cells that can send harmful signals in aging tissues. Her team identified a molecule called GDF3, produced by aged macrophages, which contributes to loss of cellular function in organs such as the liver and muscle. The funding will allow her to test whether blocking this signal can improve healthspan.
Beyond advancing the science, the award provides vital support for her research team and highlights the broader importance of aging research, a field with far-reaching implications for society and human health.
Back to News
Empowering Innovation Through Global Conferences and Events.
© 2025 SciInov. All Rights Reserved.